Natural or experimental infections of animals with Salmonella result in stimulation of both humoral and cell-mediated immunity (8, 10) . These immune responses primarily occur against the lipopolysaccharide (LPS) and major outer membrane (OM) proteins, including porins and OmpA (1, 7, 21, 28, 40, 42) . However, the number and variety of antibodies with distinct specificities and the identity of epitopes that they recognize are not well understood. Previous studies (reviewed in references 40 and 42) established the importance of O-antigenspecific antibodies in immunity to murine salmonellosis. The precise role of porins, however, in humoral immunity is controversial (reviewed in reference 40) .
OmpA, like porins and LPS, is also a target of the host immune response (1, 19, 28, 31, 48) , but its role in immunoprotection is not clearly understood. Some studies suggest that antibodies specific for OmpA or its homolog do not confer passive protection (13, 20, 49, 51) . On the other hand, several investigators have shown that the C-terminal domain of OprF, the OmpA homolog in Pseudomonas aeruginosa, contains an important protective epitope (14, 15, 50) .
The OmpA protein, a major Salmonella enterica serovar Typhimurium OM protein that is 94% identical to Escherichia coli OmpA (12) , is of particular interest for immune recognition analysis. The majority conformers of OmpA fold into a structure with two large domains, the N-terminal domain (residues 1 to 170 in E. coli) and the C-terminal domain (residues 196 to 325). The N-terminal domain of E. coli OmpA was crystallized as an eight-stranded ␤-barrel (30) , and this domain is believed, like other ␤-barrel-structured porins, to be inserted into the OM. In contrast, the C-terminal domain of OmpA and homologs contains a peptidoglycan-association motif (17; R. De Mot and J. Vanderleyden, Letter, Mol. Microbiol. 12:333-334, 1994), apparently forms an ␣-helix-rich structure (47) , and is located in the periplasmic space. The N-terminal ␤-barrel cannot form a large channel (30) . However, Sugawara and Nikaido (46) showed that OmpA also contains a minority conformer, estimated to comprise about 2 to 3% of the population, that forms channels allowing the diffusion of solutes up to several hundred daltons in size, explaining the low-efficiency porin activity of OmpA and OprF. More-recent studies showed that these minority conformers are formed only when the Cterminal domains were present (2, 6) , suggesting that the Cterminal domains participate in the production of larger ␤-barrels, thus presumably exposing portions of the C-terminal domains on the cell surface. The presence of these two conformers may be reflected in the way anti-OmpA antibodies react with the surface of intact cells.
In this study we report the isolation and characterization of a panel of monoclonal antibodies (MAbs) against Salmonella OmpA and show that a single, highly conserved, sequential epitope on the C-terminal domain of OmpA was immunodominant in the mouse response to infection by serovar Typhimurium. Furthermore, our data suggest that the C-terminal domain is often hidden in the periplasmic space but may also become exposed, less frequently, on the cell surface.
MATERIALS AND METHODS
Mice. BALB/c mice were used for preparation of anti-OmpA MAbs, whereas CAF 1 (BALB/cJ ϫ A/J) F 1 mice (Ity r ) were used for preparation of immune polyclonal sera and immunoprotection studies. Both strains of mice were obtained from Jackson Laboratories, Bar Harbor, Maine.
Bacterial strains and growth conditions. Serovar Typhimurium strains WB600 (wild-type) and SH5014 (rfa mutant) and E. coli strain HN705 (⌬ompC ompF::Tn5) have been previously described (37, 40, 42, 45) ; serovar Typhimurium strains SA1627 (rfb [26] ) and SL1917 (galE496 ompA202 [44] ) were provided by Ken Sanderson and Bruce Stocker, respectively. Clinical isolates of enteric and nonenteric bacteria, as well as the culture media and growth conditions for enteric and nonenteric bacteria, were previously described (41) .
Salmonellae for injection were grown from frozen stocks (40) , harvested, washed once, and suspended in sterile Ringer's lactate solution (Abbott Laboratories). The number of CFU per milliliter was determined by viable counts on blood agar and bismuth sulfite agar (Difco).
Isolation and purification of OmpA, porins, OM, and LPS. Attempts were made to purify native OmpA proteins from cell envelopes of serovar Typhimurium SH5014 and E. coli HN705, following the protocol of Sugawara et al. (47) . However, OmpA from Salmonella was contaminated with porins and thus had to be further purified by electroelution from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) slab gels (29) . The protein was dialyzed against water containing 0.1% SDS and then concentrated with solid polyethylene glycol 20000 (Fisher). Salmonella porins, OM, and LPS were isolated and purified from serovar Typhimurium strain SH5014 as previously described (38) .
Anti-Salmonella MAbs. BALB/c mice were immunized intraperitoneally (i.p.) with heat-killed whole cells of strain SH5014 (four times with 10 8 cells at 2-week intervals), and spleens were removed on the third day after the last injection. Mice were also immunized via the footpads with purified OmpA. Cell fusion was carried out as previously described (37) . Hybridomas were selected in hypoxanthine-aminopterin-thymidine medium. Culture fluids from wells with colonies were assayed by enzyme-linked immunosorbent assay (ELISA) against OmpA, porins, OM, LPS, and whole cells of serovar Typhimurium strains SH5014 (rfa), SA1627 (rfb), and SL1917 (galE ompA). Hybridomas of interest were cloned twice by limiting dilution and injected into BALB/c mice for production of ascitic tumors. The class and subclass of MAbs were determined by ELISA with goat antisera against mouse heavy and light chains , ␥ 1 , ␥ 2a , ␥ 2b , ␥ 3 , , and (Fisher).
Antibody concentrations of ascites fluid were calculated from a standard curve using isotype-specific, affinity-purified goat anti-mouse immunoglobulins (Ig) as previously described (40) .
MAb purification and biotinylation. Anti-OmpA MAbs were purified by protein G affinity chromatography and biotinylated with Immunopure NHS-LCBiotin (Pierce) as previously described (41, 42) .
ELISA. ELISA was performed as previously described (37, 42) . Competitive inhibition ELISA. A competitive inhibition ELISA was performed to identify the epitopes that are recognized by both the anti-OmpA MAbs and the polyclonal immune sera (41, 42) . Antigen-coated 96-well plates were blocked and washed as described above. Serial twofold dilutions of polyclonal serum (100 l) were added to each well (rows 1 to 11) as competitor of the binding by the biotinylated MAb, added subsequently to the antigen. A preselected quantity of biotinylated MAb (100 l) that produced an ELISA absorbance of 0.5 to 1.0 optical density units compared to the homologous antigen was added to each well (rows 1 to 12), mixed, and incubated overnight at 4°C. The plates were washed and developed with streptavidin-alkaline phosphatase and p-nitrophenylphosphate as described above. Unlabeled homologous antibody was used as a positive control for competitive inhibition. As negative controls, an unrelated mouse antibody (of the same isotype) or preimmune polyclonal serum was incubated with the biotinylated antibody. Plates containing antigen, conjugate and substrate, but without serum or biotinylated antibody, were also included throughout the experiment. The percent binding, calculated by dividing the absorbance obtained in rows 1 to 11 by the absorbance in row 12 (control), was plotted against the dilution of "cold" antiserum.
Proteolytic digestion of OmpA. The Triton-insoluble envelope fraction (1 mg of protein/ml) (9), which contains porins and OmpA, was incubated with 500 g of trypsin/ml in 10 mM Tris-HCl, pH 8.0, for 1 h at 37°C. The reaction was terminated with 2 mM phenylmethylsulfonyl fluoride, and the envelope was recovered by centrifugation at 13,000 rpm for 30 min in a microcentrifuge at 4°C. The pellet, shown to contain the N-terminal domain of OmpA by SDS-PAGE, was washed once in 10 mM Tris-HCl, pH 8.0, and was resuspended in the same buffer for ELISA.
Cyanogen bromide (CNBr) digestion of OmpA. Five milligrams of OmpA monomer was precipitated, washed with acetone, and digested with 250 mg of CNBr in 500 l of 70% (vol/vol) trifluoroacetic acid as previously described (38, 39) . The digested sample was lyophilized twice and then suspended in SDS sample buffer (1 mg/ml) and stored at Ϫ80°C for later use in gel electrophoresis.
Immune polyclonal sera. Immune polyclonal sera were prepared in CAF 1 mice against live and heat-killed cells of serovar Typhimurium wild-type strain WB600 and rfa mutant strain SH5014, as previously described (42) .
Passive immunization of mice. Generally, groups of 5 to 10 CAF 1 mice received i.p. injections with 0.2 ml of a 1/10 dilution of ascites fluid containing selected anti-OmpA MAbs. Control mice received either 0.2 ml of sterile Ringer's lactate, 1/10 dilution of P3 ϫ 63-Ag8.653 (the non-Ig secreting fusion partner) ascites, CM 12.1 (an unrelated mouse MAb of the IgG2a isotype [38, 40] ), normal mouse serum, or immune serum (as a positive control). The mice were subsequently challenged (i.p.) 60 min later with 0.2 ml of WB600 suspension containing 10 or 100 50% lethal doses (12,500 and 125,000 CFU, respectively). The protective efficacies of anti-OmpA MAbs were determined from the 21-day survival data. The median length of survival of each group of mice in which more than 50% of the animals died was estimated, and statistical analyses were performed as previously described (40) .
Flow cytometry. Intact and OM-permeabilized bacteria were stained with anti-OmpA MAbs and fluorescein-conjugated goat anti-mouse Ig (Fisher) and analyzed by cytofluorometry as previously described (41) . The OM permeabilization was carried out by an extensive modification (52) of the Ca 2ϩ treatment protocol (5) that was developed for the purpose of introducing proteins into the periplasm of living bacterial cells. It should be noted that the harsh treatment of cells in 300 mM Ca 2ϩ in the original protocol is replaced here by a mild treatment of cells with 10 mM CaCl 2 , 10 mM MgCl 2 , and 16% sucrose for 30 min on ice, followed by washing with 0.9% NaCl containing 0.001 M EGTA.
Other methods. Protein concentrations were measured with the Micro BCA protein assay reagent (Pierce), with bovine serum albumin as the standard. N-terminal sequencing of polypeptides was performed as previously described (38, 39) , after first transferring the SDS-PAGE-separated peptides onto Immobilon P polyvinylidene difluoride membranes (Millipore). SDS-PAGE was performed on either 16.5% Tris-Tricine (Bio-Rad) or 10 to 20% linear gradient polyacrylamide gels. Western blotting was performed as described previously (37) , after the electrophoretic transfer of the proteins onto nitrocellulose membrane. a MAbs with the prefixes PA and SH were produced from mice immunized with purified OmpA and heat-killed SH 5014 whole cells, respectively.
b Antibodies for ELISA were used at a dilution which resulted in an optical density at 405 nm within the range of 1.0 to 1.5 when tested with homologous antigen (immunogen) as previously described (37) . Absorbance values for ascites from the cell fusion partner P3 ϫ 63-Ag8.653, which is a nonsecretor of Igs (control), were always Ͻ0.10 at the antibody dilutions tested. Similarly, the absorbance values for the anti-OmpA MAbs against Salmonella porins, LPS, and whole cells of strain SL 1917 (OmpA Ϫ ) were also Ͻ0.1 at the antibody dilutions tested. Abbreviations: OM, outer membrane; WC, whole cells. Symbols for ELISA reactions: ϩ, weakly positive (absorbance, 0.25 to 0.5); ϩϩ, moderately positive (absorbance, 0.5 to 1.0); ϩϩϩ, strongly positive (absorbance, Ͼ1.0).
c OmpA and OM were isolated and purified from S. enterica serovar Typhimurium strain SH5014.
RESULTS
MAb specificity to OmpA. We tested a panel of 12 antiSalmonella OmpA MAbs ( Table 1) . Most of these MAbs were derived from fusions against heat-killed SH5014 whole cells (SH), but the panel also included one that was generated by the use of purified Salmonella OmpA (PA). Among the 12, we found 6 IgG2a and 6 IgG2b isotypes (Table 1) ; all contained light chains. In the ascites fluid Ig concentrations were 4 to 7 mg/ml, and ELISA titers to OmpA were 10 4 to 10 5 (data not shown).
The MAbs were initially examined for their reactivity with Salmonella OmpA, porins, OM, and LPS, as well as whole cells of strains WB600 (wild-type), SH5014 (rfa), SA1627 (rfb), and SL1917 (galE ompA), in ELISA. Positive data are shown in Table 1 . All the MAbs in the panel gave strong positive reactions with OmpA, OM, and whole cells of the rough strains (see SH5014 and SA1627 in Table 1 ), but none bound to Salmonella porins, LPS, or whole cells of wild-type or OmpA Ϫ strain (as explained in footnote b of Table 1 ). Although positive reactions seen in whole-cell ELISA may be due to inadvertent cell lysis or exposure of the antigenic sites on dead cells or OM vesicles shed by the bacteria (15, 49) , the ELISA results are consistent with our Western blot and cytofluorometric data (see below). We then examined the MAb specificity by immunoblotting with heated (100°C for 5 min in SDS) and unheated (37°C for 1 h in SDS) cell envelope extracts. The heat treatment was used to identify OmpA because its mobility on SDS-PAGE becomes lower in the completely heat-denatured or heat-modified form than in the partially denatured form present in unheated preparations (27) . We found that these antibodies recognized a protein with mobilities corresponding to 35,000 and 28,000 Da in heated and unheated samples, respectively ( Fig. 1; Fig. 2, lanes 1 and 2) . These data suggested that our panel of MAbs recognized an epitope(s) on the heatmodifiable protein OmpA that was probably sequential in nature since its recognition was not affected by the denaturation of the protein.
We performed competitive binding assays (see Materials and Methods) with anti-OmpA MAbs to determine whether these antibodies recognized the same or different epitopes on OmpA. We found the binding of each biotinylated MAb was decreased by the presence of the other, nonbiotinylated MAbs 4) and after (lanes 5 and 6) treatment with trypsin was suspended in SDS sample buffer and then either boiled at 100°C for 5 min (lanes 1, 3, 5, and 6) or solubilized at 37°C for 1 h (lanes 2 and 4). Proteins were separated by SDS-PAGE and immunoblotted (Fig. 1) MAbs were specific to the C-terminal domain of OmpA. The majority conformer of OmpA is separated into two large domains, the N-terminal domain and the C-terminal domain. Trypsin treatment of cell envelope is known to degrade the C-terminal domain but leaves the N-terminal domain of approximately 24,000 Da intact (18) . In our studies, the antiOmpA MAbs in the panel did not react with the trypsintreated crude OM (Triton-insoluble envelope) ( Fig. 2; lane 5) . Thus, these antibodies recognized an epitope(s) that was probably localized to the C-terminal domain of OmpA.
OmpA from serovar Typhimurium and E. coli were split into fragments with CNBr. We detected at least three to five bands (fragments, in E. coli and Salmonella, respectively) with estimated molecular masses ranging from 24,200 to 7,400 Da ( Fig.  4; lanes 1 and 4) . Analysis of these fragments for their immunoreactivity with anti-OmpA MAbs revealed a strong binding of these antibodies to a band with an approximate molecular mass of 24,200 Da in Salmonella (Fig. 4, band S1, lane 2) . In E. coli, the antibodies bound to two bands with an approximate molecular mass of 22,800 Da (band E1) and 16,900 Da (Fig. 4 , band E2, lane 5). These protein bands were transferred to polyvinylidene difluoride membranes, excised, and sequenced. The Salmonella fragment S1 (N-terminal sequence: VWRAD. . .) contained residues 101 to 329 (Fig. 5) . The E. coli fragment E2 (N-terminal sequence: LSLGV. . .) contained residues 162 to 325. Band E1, however, contained two peptides with N-terminal sequences LSLGV. . . (major component) and GESNP. . . (minor component). These correspond to residues 162 to 325 and residues 280 to 325, respectively (Fig. 5) . The observed molecular weights of S1, E1, and E2 fragments were comparable to the molecular weights of 24,553, 22,494, and 17,545, respectively, expected from the sequences. CNBr thus cut OmpA after Met 100 in Salmonella and Met 161 and Met 279 in E. coli, but apparently the cleavage at Met 283 (and at   FIG. 3 . Recognition of similar epitopes by anti-OmpA MAbs. Studies of MAb competition for binding to OmpA were carried out by competitive inhibition ELISA. Plates were coated with the homologous antigen (purified Salmonella OmpA or heat-killed whole cells of strain SH5014). Unbiotinylated MAbs were added at various concentrations (2.0 to 0.016 g/ml) followed by the biotinylated MAbs at a preselected concentration that yielded an absorbance of 0.5 to 1.0 at 420 nm versus the homologous antigen. ELISA was then carried out as described in Materials and Methods. Unrelated IgG2a and IgG2b mouse antibodies were used as negative controls (A), whereas unlabeled homologous MAbs were used as positive controls (A) in the competition experiments (B).
FIG. 4. CNBr cleavage of
OmpA and reaction of the fragments with MAb SH16.2. The CNBr-generated peptides from Salmonella and E. coli were separated by SDS-PAGE and immunoblotted (Fig. 1) . Lanes 1 and 4 contain the CNBr peptides as separated on the SDS gel, lanes 2 and 5 contain the immunoblots of MAb SH16.2 with these peptides, and lanes 3 and 6 contain the control strips probed with ascites fluid from Ag.8.
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Met 279) was incomplete (Fig. 5) . The association of a small peptide (residues 280 to 325) with a much larger peptide (residues 162 to 325) in fragment E1 of E. coli was unexpected; however, such anomalous electrophoretic behavior has been reported for other OM protein fragments (see reference 39). The E. coli fragment E2 (residues 162 to 325) in any case contains only the C-terminal domain (22, 35) , and its reactivity with MAb SH16.2 confirms the location of epitope in the C-terminal domain. The C terminus epitope is conserved. Western blotting showed that anti-OmpA MAb SH16.2 cross-reacted with at least 9 of the 12 other enterobacterial species tested (see Fig.  1 ). However, this and other MAbs did not bind to proteins in the nonenterobacterial species such as Aeromonas hydrophila, Bordetella pertussis, Brucella suis, Haemophilus influenzae, Neisseria gonorrhoeae, and P. aeruginosa (data not shown). These results indicated that the OmpA epitope recognized by our panel of MAbs is widely conserved within (but not outside) the family Enterobacteriaceae.
The epitope in the C-terminal domain of OmpA is an immunodominant antigen. The significance of the OmpA epitope in the context of natural or artificial infection was examined first by following the course of humoral immune response in mice with live or heat-killed cells of either S-form WB600 or an Ra mutant SH5014. We found that the highest titer to OmpA was reached on day 21 and the titer remained high up to day 42 (data not shown). The ELISA titer of sera to OmpA varied from approximately 1.0 ϫ 10 4 to 4.1 ϫ 10 4 and, in general, was higher when mice were given heat-killed cells than when they were given the live organisms (data not shown). The primary antibody against OmpA belonged to the IgG2a subclass in mice given the live as well as heat-killed cells (data not shown). These data on the humoral immune response are consistent with those reported earlier by Singh et al. for the Salmonella porins (42) .
We then examined the content of anti-OmpA antibodies in these polyclonal sera by competition binding assays with biotin-labeled MAbs. The immune sera used were previously shown to also contain antibodies to other OM proteins and LPS (42) . Similar competition data were obtained with each of the three polyclonal sera (days 14, 21 , and 28) we tested; data obtained with sera from day 21 are shown in Fig. 6 . Positive and negative control results from this assay are presented in Fig. 3A ; an additional negative control, NMS at a 1:40 dilution, inhibited binding only by approximately 15% (Fig. 6) . With all the polyclonal sera (raised to live or heat-killed, WB600 or SH5014 cells), 50% inhibition of the binding of MAbs occurred with serum concentrations between 0.3 and 1% (Fig. 6) . In earlier studies using anti-O4 and antiporin MAbs, 50% inhibition was obtained over a similar range of concentrations of the same polyclonal sera, except for one anti-O4 MAb (42) . Thus, the epitope(s) located on the C-terminal domain of OmpA is Table 2) . Accessibility of the OmpA epitope on the cell surface. The C-terminal domain of the majority conformer of OmpA is buried in the periplasm (see the Introduction), and it was unexpected to see MAbs directed to this domain reacting with intact cells of even strains with R-form LPS (SH5014 or SH1627) ( Table 1) . We therefore studied the issue of surface accessibility of this epitope in depth.
Before we investigated on which side of the membrane this epitope was located, we had to examine whether O chains of LPS hindered access of MAbs to the antigen, as has been the case with the surface epitopes of porin (4) . Indeed, by ELISA, the MAbs showed strong binding to whole cells of Salmonella R mutants (SH5014 and SH1627) but did not react with those of the smooth strains of Salmonella (WB600) ( Table 1) . Thus, the epitope on the cell surface was not readily accessible for MAbs if the O antigen of LPS was present. This is consistent with earlier reports of the physical shielding of surface epitopes of porin proteins by the O chains in wild-type Salmonella (reviewed in reference 40). However, MAb SH16.2 bound to whole cells of E. coli (clinical isolate), Citrobacter amalonaticus, and Shigella boydii by ELISA, suggesting that O chains of these bacteria did not strongly hinder the access of MAb to OmpA (data not shown).
To obtain more-detailed information on the localization of the OmpA epitope, we investigated the binding of SH16.2 to the enteric bacteria at the individual-cell level with cytofluorometry. This method quantitates MAb binding to surface epitopes on intact live bacteria, while excluding cell ghosts and debris from analysis by forward scatter-side scatter gating (16) . We found that the mean fluorescence values of serovar Typhimurium rough strain SH5014 (rfa), and E. coli (clinical isolate) were approximately two to two and a half times the signal obtained with serovar Typhimurium strain SL1917 (OmpA Ϫ ) (Fig. 7) . Serovar Typhimurium strains SA1627 (rfb) and WB600 (wild-type) gave mean fluorescence values that were similar to those obtained with SH5014 and SL1917, respectively (data not shown). We further examined the binding of SH16.2 to Salmonella SH5014 and E. coli cells whose OM had been permeabilized for the entry of proteins, as described in Materials and Methods. The data indicate that the OM permeabilization resulted in an ϳ2.5-to 3-fold increase in both the number and the mean fluorescence intensity of the cells stained (Fig. 7) . These results suggest that a major portion of the SH16.2 epitope is located in the periplasm but a minor portion of it is indeed exposed on the cell surface.
DISCUSSION
OmpA is a major OM protein in E. coli and other enteric bacteria (3, 18, 27) . In this study, we showed that the major epitope of the Salmonella OmpA is located in its C-terminal half. These data confirm the strong immunogenicity of the C-terminal domain (31) and are also consistent with the observation that some of the major epitopes of OprF, a homolog of OmpA in P. aeruginosa, are located in its C-terminal domain (14, 23, 33) . Furthermore, examination of mouse polyclonal sera after immunization with live or heat-killed whole cells of Salmonella showed that the OmpA epitope bound by our panel of MAbs was an immunodominant antigen. This epitope of OmpA appears similar in its importance to other immunodominant epitopes of Salmonella that are present on the surface of OmpC porin and in LPS O4 factor (42) . However, anti-OmpA MAbs, like antiporin antibodies, could not protect mice against Salmonella infection, possibly because the access of the antibody to these proteins on the surface of OM was limited by the O chains of the LPS. Vuopio-Varkila et al. (51) also reported that anti-OmpA polyclonal sera failed to protect against challenge with the encapsulated E. coli O18:K1. FIG. 6 . Immune recognition of the OmpA epitope in mice. Competition for binding to the epitope on the C-terminal domain by anti-OmpA MAbs and the immune mouse sera raised against serovar Typhimurium strains WB600 (wild type) (A) and SH5014 (rfa) (B) was measured by competitive ELISA. Plates were coated with the homologous antigen (see Fig. 3 ), blocked, and filled with serial twofold dilutions of preimmune normal mouse serum (NMS) or immune mouse serum raised against live (LV) or heat-killed (HK) serovar Typhimurium strain WB600 (WB) or SH5014 (SH). A preselected concentration of biotinylated MAb that yielded an absorbance of 0.5 to 1.0 at 420 nm versus the homologous antigen was added to each well, the well contents were mixed, and the plate was incubated overnight at 4°C. The plates were washed and developed with streptavidin-alkaline phosphatase as described in Materials and Methods.
Since our panel of anti-OmpA MAbs binds purified OmpA, OM, and intact rough strains of Salmonella and several other enteric bacteria in ELISA and shows some binding to intact cells by flow cytometry, we believe that this epitope is at least to some extent exposed on the cell surface. This is at first sight surprising, (i) because the majority of the OmpA population is known to fold into a two-domain structure, with the N-terminal half forming an eight-stranded ␤-barrel traversing the OM and the C-terminal half forming a periplasmic, globular domain (17, 22, 30, 47) and (ii) because this model predicts that the C-terminal half, buried in the periplasm, should be inaccessible to MAbs in intact cells. However, Sugawara and Nikaido (46) showed that both OmpA and OprF fold into two alternative conformations, a majority one with essentially closed pores and a minority one with open channels. ␤-Barrels each containing at least a dozen or more ␤-strands would be needed to produce open channels that allow diffusion of solutes of several hundred daltons (45) , and indeed, Arora et al. (2) showed that the entire OmpA sequence is needed to produce large, open channels. It is therefore likely that the minority, open conformers of OmpA fold like a classical porin, with many ␤-strands, as was predicted (incorrectly for the majority population) previously (43) . In this conformer, the loops in the C-terminal half will be exposed on the external surface of the OM and should be accessible for MAbs. Indeed, site-specific labeling showed that in the open conformers of OprF, an OmpA homolog, parts of the C-terminal half were exposed on the cell surface (Sugawara and Nikaido, unpublished data).
Since 2 to 3% of the OmpA population is in the open conformation (46) , and since there are about 50,000 molecules of OmpA per E. coli cell (25) , it is understandable that MAb specific for the C-terminal epitope reacted to OmpA in intact cells, presumably to these open conformers (Table 1) . However, MAb would be able to react much more strongly if it could gain access to the cognate epitope present in the Cterminal, periplasmic domain of the majority conformers of OmpA. This is presumably reflected by the two-to threefold increase in MAb reactivity in OM-permeabilized intact cells (Fig. 7) . We emphasize that the permeabilization of the OM was carried out under very mild conditions, using only 10 mM CaCl 2 in the presence of 10 mM MgCl 2 and 16% sucrose, conditions that are not expected to remove LPS and thereby increase the accessibility of already surface-exposed OmpA epitopes.
In a homologous system of P. aeruginosa OprF, a folding model composed of porin-like 16 transmembrane ␤-strands was prevalent, in large part because the MAbs directed to epitopes in the C-terminal half reacted with intact cells of this organism (33) . Additionally, peptides from the C-terminal half, corresponding to residues 261 to 274 and 305 to 318 of OprF, elicited whole-cell-reactive antibodies (14, 15, 50), a result not expected if the C-terminal domain is always located in the periplasm. A monoclonal antibody directed against the C terminus also reacted with the intact bacterium (34) . However, the present study suggests that qualitative demonstration of antibody binding to intact cells is not sufficient, because the protein may have more than one final conformations; a comparison of untreated versus OM-permeabilized cells would have been instructive. In fact, a circular dichroism study (47) showed clearly that the majority conformer of OprF contains a large ␣-helical (presumably periplasmic) domain just as OmpA does and that the folding model proposed by Rawling et al. (33) is incorrect. The presence of a minority conformer, which forms large channels by utilizing the entire sequence including the C-terminal half, was recently shown also for OprF (6) .
The molecular mechanism of pore formation by OmpA/ OprF family proteins has been controversial (24) . However, now all the results, including direct functional fractionation (46) , planar bilayer studies (2, 6), X-ray crystallography of the N-terminal half (30) , and antibody accessibility studies (reference 33 and the present study), are consistent with a unified model in which the proteins fold into two alternative conformations, a two-domain, closed channel conformation and a one-domain, open channel conformation. (This is likely to be true with any member of this family. Indeed, a recent report suggests that the C-terminal end of MopB, the OmpA homolog in Methylococcus capsulatus, also contains surface-exposed regions [11] .) Crystallography obviously favors more abundant conformers, and furthermore the N-terminal half, which has no possibility of forming a channel alone, was used as the material (30) . Clearly the successful crystallization of the N-terminal domain is not a proof that the whole protein cannot take another conformation with open channels. The proteins of OmpA/OprF family are known to be important for the stabilization of the envelope structure, presumably because a CAF 1 female mice (7 to 9 weeks old, weighing 20 to 22 g) received injections (i.p.) with 0.2 ml of individual ascites. Control mice received either 0.2 ml of immune mouse serum (positive control), normal mouse serum, sterile Ringer's lactate, Ag.8 ascites, or an unrelated mouse MAb (CM12.1 [38, 40] ) of the IgG2a isotype. The mice were subsequently challenged (i.p.) 60 min later with 0.2 ml containing either 10 (12,500 CFU) or 100 (125,000 CFU) 50% lethal doses (LD 50 s) of S. enterica serovar Typhimurium strain WB600. The protective efficacies of anti-Salmonella MAbs and the immune polyclonal serum were determined from the 21-day survival data as previously described (40) .
b See Table 1 for the isotype of anti-OmpA MAbs. Immune polyclonal mouse serum was prepared by infecting mice with sublethal doses of S. enterica serovar Typhimurium WB600 as previously described (40) .
c All dilutions were made in sterile Ringer's lactate. d The median length of survival of each group of mice in which more than 50% of the animals died was estimated by calculating the reciprocal mean length of survival in days postchallenge of each animal in the group as previously described (40) .
e S. enterica serovar Typhimurium WB600 cells were grown, harvested, and suspended in sterile Ringer's lactate solution. The number of CFU per milliliter was estimated by measurement of optical density at 420 nm (optical density of 1 ϭ 1.5 ϫ 10 8 CFU/ml). The actual number of CFU was determined by viable count on blood agar and bismuth sulfite agar.
f Statistical analyses were carried out as previously described (40) . P Յ 0.005. (17) . This is likely to be the main function of the majority conformer of these proteins. Finally, it should be added that the OmpA epitope bound by our panel of MAbs, because it is widely conserved, immunodominant, and antibody-accessible at least in partially rough mutants, may provide a site for insertion and expression of foreign genes in Salmonella strains (32, 36) . 
